Novo Nordisk A/S Price Today
Novo Nordisk A/S
NVO
Healthcare
$354.16B
💰
Market Cap
38.6
💸
Price to Earnings
$4.1
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
13 |
Strong Buy |
6 |
Hold |
10 |
Sell |
2 |
Strong Sell |
1 |
NVO Price Forecast Target
156.6 👉 195.2 +25%
NVO EPS Forecast
4.1 👉 5.7 +39%
Financials
Profit Margin
32 %
Revenue Growth
27.0 %
Dividend
$ 1.76
Held Percent
0.0% - Insiders
8.2% - Institutions
91.8% - Public
Major Fund Holders
-
💰 Jennison Associates LLC $1.9B
-
💰 Renaissance Technologies, LLC $1.7B
-
💰 Fisher Asset Management, LLC $1.3B
-
💰 Bank of America Corporation $1.0B
-
💰 Envestnet Asset Management $844.9M
Stock Ideas
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…📮FAQ
Some Frequently Asked Questions.
The Novo Nordisk A/S industry is Biotechnology
The Novo Nordisk A/S sector is Healthcare
The Novo Nordisk A/S forecasted predicted Price to Earnings PE ratio is 27.7
The Novo Nordisk A/S Price to Earnings PE ratio is 38.6
The Market Capitalization of Novo Nordisk A/S is $354.16B
There are total of 12893087488 float shares with 8.2% held by Institutions and 0.0% held by insiders
The MNovo Nordisk A/S forecasted Earnings per Share EPS is $5.7
The Novo Nordisk A/S Earnings per Share EPS is 4.1
The Novo Nordisk A/S company has $148506000000 gross profits with 32 profit margins
The Novo Nordisk A/S Earnings Growth is 0.412% with 0.394% quarterly earnings growth
The Novo Nordisk A/S Revenue is $188290007040 with 0.27 revenue growth
The price target for Novo Nordisk A/S stock is $195.2 for the high target and $160.6 for the low target
The consensus analyst recommendations for Novo Nordisk A/S is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Novo Nordisk A/S is Buy, with the following breakdown:
- Buy: 13
- Strong Buy: 6
- Hold: 10
- Sell: 2
- Strong Sell: 1
The Beta of Novo Nordisk A/S is 0.3
The dividend of Novo Nordisk A/S is $1.76
The dividend yield of Novo Nordisk A/S is 0.0112%
The biggest institutional and mutual fund holders of Novo Nordisk A/S stock are
- Jennison Associates LLC
- Renaissance Technologies, LLC
- Fisher Asset Management, LLC
- Bank of America Corporation
The Novo Nordisk A/S ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0